Zurueck zur Suche

Reporte zur Charge UJ776AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

9Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 3 UT 3 KS 2 CT 1

VAERS 1865124

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ776AA

mild
Staat
CT
Alter
16,0
Geschlecht
M
Eingang
12.11.2021
Impfdatum
11.11.2021
Beginn
12.11.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Dizziness Gait disturbance Magnetic resonance imaging head normal

Symptomtext

Acute onset of dizziness and difficulty walking

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
MRI brain: normal
Aktuelle Erkrankungen
none
Vorgeschichte
asthma
Andere Medikamente
none
Allergien
caramel, sweet tarts, bee stings
Vorherige Impfungen
-

VAERS 2493612

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ776AA

gering
Staat
UT
Alter
17,0
Geschlecht
M
Eingang
31.10.2022
Impfdatum
20.10.2022
Beginn
20.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

Patient received the expired fluzone dose with no reported adverse event; Initial information received on 21-Oct-2022 regarding an unsolicited valid non-serious case received from other health professional. This case is linked to cases 2022SA442254 and 2022SA443423(CLUSTER). This case involves a 17years old female patient to whom expired fluzone dose with no reported adverse event while receiving vaccine influenza quadrival A-B vaccine [Fluzone Quadrivalent]. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. On 20-Oct-2022, the patient received suspect INFLUENZA QUADRIVAL A-B VACCINE at a total dose of 0.5 ml (lot UJ776AA, expiry date: 30-Jun-2022) (strength: standard) via intramuscular route in the left deltoid for immunization. On 20-Oct-2022 the patient developed a non-serious patient received the expired fluzone dose with no reported adverse event (expired product administered) (same day latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Action taken: Not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2493611

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ776AA

gering
Staat
UT
Alter
15,0
Geschlecht
M
Eingang
31.10.2022
Impfdatum
20.10.2022
Beginn
20.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

administered an expired Fluzone quad vaccine with no reported adverse event; Initial information received on 21-Oct-2022 regarding an unsolicited valid non-serious case received from other health professional. This case is linked to case 2022SA442254 and 2022SA443067(CLUSTER). This case involves a 15 years old male patient who administered an expired fluzone quad vaccine with no reported adverse event while receiving vaccine influenza quadrival A-B vaccine [Fluzone Quadrivalent]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 20-Oct-2022, the patient received suspect INFLUENZA QUADRIVAL A-B VACCINE at a total dose of 0.5 ml (lot UJ776AA, expiry date: 30-Jun-2022) (strength: standard) via intramuscular route in the left deltoid for immunization. On 20-OCT-2022 the patient administered an expired fluzone quad vaccine with no reported adverse event (expired product administered) (Latency: same day) Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2493217

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ776AA

gering
Staat
UT
Alter
12,0
Geschlecht
F
Eingang
29.10.2022
Impfdatum
20.10.2022
Beginn
20.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

received the expired fluzone dose with no reported adverse event; Initial information received on 21-Oct-2022 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 12 years old female patient to whom expired fluzone dose with no reported adverse event while receiving vaccine influenza quadrival A-B vaccine [Fluzone Quadrivalent]. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. On 20-Oct-2022, the patient received suspect INFLUENZA QUADRIVAL A-B VACCINE at a dose of 0.5 ml (lot UJ776AA, expiry date: 30-Jun-2022) via intramuscular route in the left deltoid for immunization. On 20-Oct-2022 the patient developed a non-serious received the expired fluzone dose with no reported adverse event (expired product administered) (same day latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Action taken: Not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2182450

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ776AA

gering
Staat
CA
Alter
-
Geschlecht
F
Eingang
16.03.2022
Impfdatum
15.03.2022
Beginn
15.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Insurance issue

Symptomtext

Vaccine Were correct ones , but the mistake was that the vaccine where from the wrong stock instead of the private which patient has private insurance.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Insurance issue
Hospital-Tage
-
Labordaten
none applicable
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2155112

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ776AA

gering
Staat
KS
Alter
0,2
Geschlecht
M
Eingang
03.03.2022
Impfdatum
04.02.2022
Beginn
-
Tage bis Beginn
-
Dosis
N/A
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Inappropriate schedule of product administration No adverse event

Symptomtext

Patient given flu vaccine too early- no adverse reactions

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2083270

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ776AA

gering
Staat
CA
Alter
0,3
Geschlecht
F
Eingang
02.02.2022
Impfdatum
22.12.2021
Beginn
22.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / OT
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

3 month old was given influenza vaccine incorrectly. It should have been given at 6 months.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
No
Vorgeschichte
No
Andere Medikamente
None
Allergien
No
Vorherige Impfungen
-

VAERS 2025329

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ776AA

gering
Staat
KS
Alter
0,7
Geschlecht
M
Eingang
11.01.2022
Impfdatum
10.01.2022
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age Wrong product administered

Symptomtext

ProQuad was given instead of Pentacel. Patient too young.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 1908665

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ776AA

gering
Staat
CA
Alter
2,0
Geschlecht
F
Eingang
30.11.2021
Impfdatum
17.11.2021
Beginn
17.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event

Symptomtext

Patient recieved vaccine FLUZONE QUADRIVALENT but she already received the "flu mist with no adverse event; Initial information was received on 17-Nov-2021 regarding an unsolicited valid non-serious case received from a other health professional and non-healthcare professional via Medical information (MI) under reference number - 00862943). This case involves a 2-year-old female patient who received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] but she already received dose of flu mist (extra dose administered). The patient's past medical treatments, concomitant medication and family history were not provided. Concomitant medications included INFLUENZA VACCINE LIVE REASSORT 3V (FLUMIST) for prophylactic vaccination. On 17-Nov-2021, the patient received a 0.5ml {total} dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot number UJ776AA and expiry date 30-Jun-2022 was reported) via intramuscular route at an unknown administration site for prophylactic vaccination (it was also reported as left leg). It was case of actual medication error due to extra dose administered (latency was on same day). At the time of report, no adverse event was reported. There were no laboratory data/results available. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
FLUMIST
Allergien
-
Vorherige Impfungen
-